Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials

Publisher： John Wiley & Sons Inc

ISSN： 1750-2640

Source： Influenza and Other Respiratory Viruses, Vol.9, Iss.4, 2015-07, pp. : 169-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Burden of influenza, respiratory syncytial virus, and other respiratory viruses and the completeness of respiratory viral identification among respiratory inpatients, Canada, 2003‐2014

By  

Influenza and Other Respiratory Viruses, Vol. 12, Iss. 1, 2018-01 ,pp. : 113-121

John Wiley & Sons Inc

Access to resources Recommend Favorite

Estimating the hospitalization burden associated with influenza and respiratory syncytial virus in New York City, 2003–2011

By  

Influenza and Other Respiratory Viruses, Vol. 9, Iss. 5, 2015-09 ,pp. : 225-233

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characterization of hospital and community‐acquired respiratory syncytial virus in children with severe lower respiratory tract infections in Ho Chi Minh City, Vietnam, 2010

By  

Influenza and Other Respiratory Viruses, Vol. 9, Iss. 3, 2015-05 ,pp. : 110-119

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevalence of human parainfluenza virus in patients with acute respiratory tract infections in Beijing, 2011–2014

By  

Influenza and Other Respiratory Viruses, Vol. 9, Iss. 6, 2015-11 ,pp. : 305-307

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical differences between respiratory viral and bacterial mono‐ and dual pathogen detected among Singapore military servicemen with febrile respiratory illness

By  

Influenza and Other Respiratory Viruses, Vol. 9, Iss. 4, 2015-07 ,pp. : 200-208

John Wiley & Sons Inc

Access to resources Recommend Favorite